Arcturus Therapeutics Holdings Inc (ARCT) earnings · rev $82.0M
These earnings events as JSON? API free 100/dayArcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
This ARCT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ARCT revenue for 2025-12-31 was $82.0M. Net income was -$65.8M. Revenue was down 46.1% from 2024-12-31 to 2025-12-31. ARCT currently screens at market cap $369.4M.
When the next ARCT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 46.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ARCT research stays on the stock page; the tape stays on the quote page.
ARCT earnings FAQ
What are ARCT's latest revenue and net income?
Latest cached Arcturus Therapeutics Holdings Inc (ARCT) revenue for Dec 31, 2025 was $82.0M. Net income was -$65.8M. Statements: https://lician.com/financials/arct
What is ARCT's latest diluted EPS?
Latest cached Arcturus Therapeutics Holdings Inc (ARCT) diluted EPS for Dec 31, 2025 was -$2.40.
What period does the latest ARCT earnings print cover?
The latest cached Arcturus Therapeutics Holdings Inc (ARCT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ARCT revenue change from the prior cached period?
Cached Arcturus Therapeutics Holdings Inc (ARCT) revenue was down 46.1% from $152.3M (Dec 31, 2024) to $82.0M (Dec 31, 2025). Statements: https://lician.com/financials/arct
Where are ARCT earnings listed?
Cached earnings facts for Arcturus Therapeutics Holdings Inc (ARCT) are listed at https://lician.com/earnings/arct. Statements: https://lician.com/financials/arct
Not investment advice.